Creative Details

Quality Score: 3/10

The advertisement promotes TEVIMBRA, a medication indicated for esophageal cancer, highlighting its differences for specific patient groups and improved survival outcomes when used with chemotherapy.

Creative Information

CID:c09fa05f-72b9-419d-9044-5c98f414f04d
CRID:25_xj66tp4o
Domain:compasinc.com
Seat:TTD
Size:728x90
Bid:$3.45
Timestamp:11/18/2025, 9:20:59 PM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess11/18/2025, 11:22:46 PM7.04s
    adomain_analysissuccess11/19/2025, 2:44:06 AM4.60s
    adomain_capturesuccess11/19/2025, 2:44:01 AM10.24s
    ad_rendersuccess11/18/2025, 11:22:39 PM30.06s
    brand_mappingsuccess11/19/2025, 2:44:04 AM2.72s

    Analysis Results

    Ad Format: banner

    Brands: Compas

    Sensitive:Pharmaceutical Products
    Quality:Adomain not match landing page domain
    Size:728x90
    Data Transferred:1302.73 KB
    Render Time:7.33 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    • Society (IAB14)
    Creative Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Landing Page:
    Total Ad Size:1321.82 KB
    Requests Made:
    URLSize (KB)
    https://cache-ssl.celtra.com/api/creatives/c177fa7a/compiled/web.js?v=102-b60a097c&secure=1&cachedVariantChoices=W10-&isPurposePreview=0607.26
    https://cdn.doubleverify.com/dvbm.js529.10
    https://cache-ssl.celtra.com/api/blobs/223982df53695d4b4c0ac5d81450c28929cd3359af6006967d2f14b385938735/Table%402x.png?transform=crush&quality=19570.37
    https://cache-ssl.celtra.com/api/blobs/2c747c961de128a17c99fb85d9670567b6e802b1a33c54b98bc1e1c86c769dd8/ellie%402x.png?transform=crush&quality=15025.93
    https://choices.truste.com/ca?pid=tradedesk01&aid=tradedesk01&cid=j7r0hz1_e8gtl6a_xj66tp4o&c=tradedesk01cont1&js=pmw0&w=728&h=90&sid=0&dsarequired=&dsabehalf=&dsapaid=&dsaparams=21.18
    https://cdn.celtra.com/ads/9013fc67/web.js?&accountId=1d489087&clickUrl=https%3A%2F%2Finsight.adsrvr.org%2Ftrack%2Fclk%3Fimp%3D0ba20ef3-5184-4428-9154-e9bfe807f489%26ag%3De8gtl6a%26sfe%3D1b4ca34c%26sig%3DXsh3r0tZzyp0cQy_QR42cP_YjrPZgsmh-fVohfPOXyo.%26crid%3Dxj66tp4o%26cf%3D9387763%26fq%3D0%26t%3D1%26td_s%3Dwww.cnn.com%26rcats%3D7sp%2C3c6%2C2gy%2Ccdz%2Cv8t%2Cenb%2Cd3i%2Cy29%26mste%3D%26mfld%3D2%26mssi%3D%26mfsi%3D%26sv%3Dkargo%26uhow%3D90%26agsa%3D%26wp%3D3.4487164%26rgz%3D39157%26dt%3DPC%26osf%3DWindows%26os%3DWindows10%26br%3DChrome%26svpid%3D113%26rlangs%3Den%26mlang%3D%26did%3D%26rcxt%3DOther%26tmpc%3D19.010000000000048%26vrtd%3D%26osi%3D%26osv%3D%26daid%3D%26dnr%3D0%26vpb%3D%26crrelr%3D%26npt%3D%26cc%3D2~KLUv_WMdqREMwwK9EABjUkW4XFtUbk1Uju2W43LDMXi53LCk8GEktroCQ81Eijth0KBJtVETphNUhMpV91aECvDI1a1HkbWiFtZUygxFfjJhUSDSp6hMJdL8eIdf9GBDmSG_RKk1UGksE7uraDc1uTtxmAvqdXdJk1voVfelDUPTPpEzV_a1ZR3M4LlBZMpjwv9C4QG91_Vvw_EP3_vc2_rMz7XM82Y5HAW52smsuAKnUyIqdD8eewTM2eGpiSI_WKRwJmpcISuFcG0xVwlTbzedtFP_lrqlQCjAwODMivO7T9v9DNN1r_thHrfjX_6EBVNalJZabZv5qZIXg0aS4Ah122lN4n4VD4alKkVjFoXheH0ckCsYHHlQSUGOrml5v2dZN_tzSvzA5QYHEU-rEIdN1Q1XtGHOMsp6xB_nrdjD7gPltBgRr4KZxYuVKvbIT2tsx0jZyvznL6VyuPRo2tG-GfAo3vfIb2LUU86TOoTbc0pa8q1cr7vvfI3TZsak6H0BGhhuZLfJEpeAVlP2DqrE2HbZ3g_yK2iVnjocvPT3qYgWdcJEEqlDK7SsEth-zVBt6Yot_yRga4ex6GjyRjSIUYbUESYaEYRZEKcD4vTLAqHLcspRxRDlb4uI0lBNy0txJf9xcGYyM1ep5y7zj25lbN_Ktv-OO6O7OyCSqUPvP3QNHTlgEqfuZNehmOh8mr4arcq46146M8Q3OEPGw9hLj9vn%26dur%3D1~KLUv_SMFoCgk7G0DABQFUAoHcHhhOW9nehC9TSJCCLj-n7gBEgxpcXZpYUIsd0g4RnZOM0lrb051eWQwV1daNkh1cFpWNVhrbmpwemVQSmFQdUlpRnVDNBC9TTI4A0AAB_zSX-SQS2olCD8rHQV6c6-bEhBKfqzOxhM.%26durs%3DODDJxq%26bdc%3D131%26idl%3DXY3007-Xxe2z3Qmx_TxR-unygpO7PnJ08lbgr7_s7UXMhF5ro%26testid%3Diavc1%2520%26fpa%3D345%26pcm%3D3%26ict%3DWiFi%26said%3Dcc2539d3-42d0-425b-9c30-822a6d3b7a73%26auct%3D1%26tail%3D1%26r%3D&expandDirection=undefined&clickEvent=advertiser&iosAdvId=&androidAdvId=&tradedesk_zipCode=39157&tradedesk_category=doubleverify-vd2iab-70&tradedesk_deviceType=PC&tradedesk_adFormat=728x90&tradedesk_advertiser=7eqxrub&externalAdServer=TradeDesk&tagVersion=html-standard-9&eas.JSVUVERfQ1JFQVRJVkVJRCUl=xj66tp4o&eas.JSVUVERfQ0FNUEFJR05JRCUl=j7r0hz1&eas.JSVUVERfREVWSUNFVFlQRSUl=PC&externalCreativeId=xj66tp4o&externalPlacementId=e8gtl6a&externalSessionId=0ba20ef3-5184-4428-9154-e9bfe807f489&externalSiteId=www.cnn.com&externalSupplierId=dtfj0z1&externalSupplierName=kargo&externalCampaignId=j7r0hz1&externalCreativeSize=728x90&gpsLat=32.42&gpsLng=-90.13&externalLineItemId=e8gtl6a&externalAudienceIds=&scriptId=celtra-script-1&clientTimestamp=1763508129.443&clientTimeZoneOffsetInMinutes=0&hostPageLoadId=719547865936713219.29
    https://choices.trustarc.com/get?name=pmw2.js19.05
    https://cache-ssl.celtra.com/api/static/vb60a097c/runner/clazzes/Weather/sunnyclouds1.png10.03
    https://cache-ssl.celtra.com/api/blobs/7965b61a04884a6272e31d064eb0afc8a7a4feb59b444aec433d59f500cb5af1/Explore%20improved%20survival%20outcomes%20with%20TEVIMBRA%20%2B%20chemo%402x.png?transform=crush&quality=1503.45
    https://cache-ssl.celtra.com/api/blobs/283aef09f0b061a30994512484a567d211743df66a285aab6f9f5007c8b13e00/logo%402x.png?transform=crush&quality=150&resize=240x543.38

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1Creative Screenshot 2Creative Screenshot 3